Literature DB >> 6601113

Evaluation of the cefonicid disk test criteria, including disk quality control guidelines.

A L Barry, R N Jones, C Thornsberry.   

Abstract

Cefonicid (SKF 75073) is a second-generation cephalosporin which has a spectrum of antimicrobial activity similar to that of cefamandole, but cefoxitin (a cephamycin) and cephalothin have uniquely different spectra of activity. The second-generation cephalosporins tested displayed comparable susceptibility to beta-lactamases and inhibited type I beta-lactamases. Although cefonicid has a longer serum half-life (3 to 4 h) compared with the currently used drugs, the same minimal inhibitory concentration breakpoints separating susceptible and resistant categories were applied to tests with cefonicid, cefamandole, and cephalothin. Regression analysis of the disk diffusion test results confirmed the use of identical zone size breakpoints for 30-micrograms cefonicid, cefamandole, and cephalothin disks: all three produced similar parabolic regression lines. Further analysis of disk test data confirmed the fact that cefonicid and cefamandole disks might be used interchangeably. But for routine tests, cefonicid disks might be preferred in order to minimize the number of very major (false-susceptible) interpretive errors. Suggested cefonicid 30-micrograms disk interpretive criteria are: susceptible, greater than or equal to 18 mm (less than or equal to 8.0 micrograms/ml), and resistant, less than or equal to 14 mm (greater than 16 micrograms/ml). Quality control zone diameter limits were calculated from data obtained in a multilaboratory collaborative study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601113      PMCID: PMC272613          DOI: 10.1128/jcm.17.2.232-239.1983

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Interpretive criteria for cefamandole and cephalothin disk diffusion susceptibility tests.

Authors:  A L Barry; F D Schoenknecht; S Shadomy; J C Sherris; C Thornsberry; J A Washington; R B Kammer
Journal:  Antimicrob Agents Chemother       Date:  1979-01       Impact factor: 5.191

2.  Cefuroxime, an in vitro Comparison with Six Other Cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Proc R Soc Med       Date:  1977

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  SK&F 75073, new parenteral broad-spectrum cephalosporin with high and prolonged serum levels.

Authors:  P Actor; J V Uri; I Zajac; J R Guarini; L Phillips; D H Pitkin; D A Berges; G L Dunn; J R Hoover; J A Weisbach
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

5.  Reassessment of the "class" concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins.

Authors:  A L Barry; C Thornsberry; R N Jones; P C Fuchs; T L Gavan; E H Gerlach
Journal:  Am J Clin Pathol       Date:  1978-12       Impact factor: 2.493

6.  Indirect method for assessing the penetration of beta-lactamase-nonsusceptible penicillins and cephalosporins in Escherichia coli strains.

Authors:  M H Richmond; D C Clark; S Wotton
Journal:  Antimicrob Agents Chemother       Date:  1976-08       Impact factor: 5.191

7.  Cefonicid: a stable beta-lactamase inhibitor.

Authors:  R J Mehta; D J Newman; B A Bowie; C H Nash; P Actor
Journal:  J Antibiot (Tokyo)       Date:  1981-02       Impact factor: 2.649

8.  In vitro evaluation of pyridine-2-azo-p-dimethylaniline cephalosporin, a new diagnostic chromogenic reagent, and comparison with nitrocefin, cephacetrile, and other beta-lactam compounds.

Authors:  R N Jones; H W Wilson; W J Novick
Journal:  J Clin Microbiol       Date:  1982-04       Impact factor: 5.948

9.  Role of a cefoxitin-inducible beta-lactamase in a case of breakthrough bacteremia.

Authors:  D G Beckwith; J A Jahre
Journal:  J Clin Microbiol       Date:  1980-10       Impact factor: 5.948

10.  In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.

Authors:  R N Jones; A L Barry; C Thornsberry; H W Wilson
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

View more
  4 in total

1.  Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam.

Authors:  P A Bradford; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

Review 2.  Cefonicid. A review of its antibacterial activity, pharmacological properties and therapeutic use.

Authors:  E Saltiel; R N Brogden
Journal:  Drugs       Date:  1986-09       Impact factor: 9.546

3.  Comparative in vitro evaluation of cefonicid, cefazolin, and penicillin against viridans group streptococci isolated from blood.

Authors:  M P Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Antimicrobial resistance and the presence of extended-spectrum beta-lactamase genes in Escherichia coli isolated from the environment of horse riding centers.

Authors:  Katarzyna Wolny-Koładka; Anna Lenart-Boroń
Journal:  Environ Sci Pollut Res Int       Date:  2018-05-23       Impact factor: 4.223

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.